New Developments

International coverage of treatments and trials, with the ability to zoom in on countries we cover. From approved options to compassionate access.

Live Breakthroughs Feed

All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient StoriesFDA Approved ×
FDA ApprovedUnited StatesChina

New Pill for Mantle Cell Lymphoma After Prior Treatment

Beqalzi (sonrotoclax) — oral BCL-2 inhibitor for R/R mantle cell lymphoma after ≥2 lines including a BTK inhibitor

FDA accelerated approval on 13 May 2026 for Beqalzi (sonrotoclax) tablets — an oral BCL-2 inhibitor — for adults with relapsed or refractory…

This is for adults with relapsed or refractory mantle cell lymphoma who have already had at least two…

FDA ApprovedUnited StatesCanadaUnited KingdomChinaEuropean Union

New Pill When the Heart Muscle Is Too Thick

Myqorzo (aficamten) for obstructive hypertrophic cardiomyopathy

The FDA, Europe, the UK, and China have labelled aficamten for symptomatic obstructive HCM in adults. England's NHS has a 30-day funding clock from NICE.…

The FDA, Europe, the UK, and China have labelled aficamten for symptomatic obstructive HCM in adults.…